Christopher Martell's most recent trade in Candel Therapeutics Inc was a trade of 14,240 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Christopher Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Christopher Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Christopher Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Christopher Martell | Director | Purchase of securities on an exchange or from another person at price $ 1.92 per share. | 08 Dec 2022 | 23,950 | 152,000 | - | 1.9 | 45,984 | Common Stock |
| Candel Therapeutics Inc | Christopher Martell | Director | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 08 Dec 2022 | 3,050 | 128,050 | - | 1.7 | 5,124 | Common Stock |
| Candel Therapeutics Inc | Christopher Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) |